Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Journal of Molecular Biology|February 21, 1997
Binding of amino acid side-chains to S1 cavities of serine proteinasesW Lu, I Apostol, M A Qasim, et al.Journal of Pharmaceutical Sciences|January 6, 1999
Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modificationsB A Kerwin, M J Akers, I Apostol, et al.Biophysical Chemistry|September 23, 2003
Structural genomics of Mycobacterium tuberculosis: a preliminary report of progress at UCLACelia W Goulding, L Jeanne Perry, Daniel Anderson, et al.Gynecologic Oncology|May 24, 2024
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational statusClaudia Marchetti, Beyhan Ataseven, Anna M Perrone, et al.Nature|May 1, 2007
Atomic structures of amyloid cross-beta spines reveal varied steric zippersMichael R Sawaya, Shilpa Sambashivan, Rebecca Nelson, et al.Journal of the American Society of Nephrology : JASN|March 24, 2022
Immunosuppressant Medication Use in Patients with Kidney Allograft Failure: A Prospective Multicenter Canadian Cohort StudyGreg Knoll, Patricia Campbell, Michaël Chassé, et al.Gynecologic Oncology|August 10, 2025
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variantAdriana I Apostol, Joanne Kotsopoulos, Jacek Gronwald, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2026
Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2Adriana I Apostol, Jacek Gronwald, Cezary Cybulski, et al.Current Oncology (Toronto, Ont.)|December 24, 2025
The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1Joanne Kotsopoulos, Adriana I Apostol, Kelly Metcalfe, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 2001
Predicting the reactivity of proteins from their sequence alone: Kazal family of protein inhibitors of serine proteinasesS M Lu, W Lu, M A Qasim, et al.Pageof 8